MoneyWorks4Me

Concord Drugs informs about outcome of board meeting

02 Jun 2022 Evaluate

Concord Drugs has informed the exchange that at the Board meeting held on 01.06.2022 at the registered office of the Company, the following were considered and approved by the Board; Appointment of K. Sumeela as additional director of the Company in Independent category with effect from 01.06.2022 and Resignation of P. Chandrakala as Independent Director of the Company with effect from 01.06.2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..